V

Ventyx Biosciences

71 employees

Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Biopharma

Date founded

2018

Funding rounds raised

Total raised

$177M

from 27 investors over 27 rounds

V

Ventyx Biosciences raised $177M on September 19, 2022

Investors: Great Point Partners, Walleye Capital, Logos Global Management, LP, CaaS Capital Management, Woodline Partners LP, Vivo Capital, Redmile Group and Driehaus Capital Management LLC

V

Ventyx Biosciences raised $51M on September 20, 2021

Investors: Third Point LLC, Qiming Venture Partners USA, Surveyor Capital, Vivo Capital, venBio Partners, RTW Investments, LP, OrbiMed Advisors, Logos Global Management, LP and Wellington Management

V

Ventyx Biosciences raised $114M on March 9, 2021

Investors: Qiming Venture Partners USA, Third Point LLC, OrbiMed Advisors, venBio Partners, Logos Global Management, LP, Surveyor Capital, Wellington Management, RTW Investments, LP, Vivo Capital and -

FAQ